ABO-incompatible liver transplantation using only rituximab for patients with low anti-ABO antibody titer

BACKGROUNDS/AIMS: Graft survival after ABO-incompatible (ABOi) living donor liver transplantation (LDLT) has increased due to advances in desensitization methods. We analyzed early outcomes following ABOi LDLT using only rituximab without any additional desensitization methods in recipients with low...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Hepatobiliary Pancreat Surg
Autors principals: Lee, Boram, Choi, YoungRok, Han, Ho-Seong, Yoon, Yoo-Seok, Cho, Jai Young, Jeong, Sook-Hyang, Kim, Jin-Wook, Jang, Eun Sun, Ahn, Soomin
Format: Artigo
Idioma:Inglês
Publicat: Korean Association of Hepato-Biliary-Pancreatic Surgery 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6728259/
https://ncbi.nlm.nih.gov/pubmed/31501808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14701/ahbps.2019.23.3.211
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars